Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 161-171

  Kim, Hyun Soo ^a   Park, Sun Jin ^a   Lee, Kil Yeon ^a   Park, Yong Koo ^a   Kim, Youn Wha ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Colorectal carcinoma; Liver; Metastasis; Raf kinase inhibitor protein; Recurrence

Indexed keywords

RAF PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HEPATIC COLORECTAL METASTASIS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; RISK ASSESSMENT; SURVIVAL RATE; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROPORTIONAL HAZARDS MODELS;

EID: 84861551436     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1797     Document Type: Article

References (45)

1. Calvert PM and Frucht H: The genetics of colorectal cancer. Ann Intern Med 137: 603-612, 2002.
2. Wang X, Wang Q, Hu W and Evers BM: Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB- dependent pathway. Oncogene 23: 1885-1895, 2004. (Pubitemid 38445414)
3. Fang JY and Richardson BC: The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6: 322-327, 2005. (Pubitemid 40590269)
4. Yeung K, Seitz T, Li S, et al: Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401: 173-177, 1999. (Pubitemid 29436321)
5. Granovsky AE and Rosner MR: Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 18: 452-457, 2008. (Pubitemid 351498852)
6. Chatterjee D, Bai Y, Wang Z, et al: RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279: 17515-17523, 2004. (Pubitemid 38560515)
7. Woods Ignatoski KM, Grewal NK, Markwart SM, et al: Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys 72: 153-160, 2008.
8. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA and Bonavida B: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 179: 5441-5453, 2007.
9. Fu Z, Smith PC, Zhang L, et al: Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95: 878-889, 2003. (Pubitemid 36833879)
10. Cunningham D, Pyrhonen S, James RD, et al: Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352: 1413-1418, 1998. (Pubitemid 28510874)
11. Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318, 1999.
12. Nordlinger B, Vaillant JC, Guiguet M, et al: Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 12: 1491-1496, 1994. (Pubitemid 24206250)
13. DeMatteo RP, Fong Y, Jarnagin WR and Blumgart LH: Recent advances in hepatic resection. Semin Surg Oncol 19: 200-207, 2000.
14. Petrowsky H, Gonen M, Jarnagin W, et al: Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235: 863-871, 2002. (Pubitemid 34547306)
15. Bosman FT, Carneiro F, Hruban RH and Theise ND: WHO Classification of Tumours, Pathology and Genetics: Tumours of the Digestive System. IARC Press, Lyon, 2010.
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. Springer, New York, NY, USA, 2010.
17. Al-Mulla F, Hagan S, Al-Ali W, et al: Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61: 524-529, 2008. (Pubitemid 351518239)
18. Al-Mulla F, Hagan S, Behbehani AI, et al: Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24: 5672-5679, 2006. (Pubitemid 46631308)
19. Kim HS, Kim GY, Lim SJ and Kim YW: Expression of Raf-1 kinase inhibitory protein in extrahepatic bile duct carcinoma. Korean J Pathol 44: 234-242, 2010.
20. Kim HS, Kim GY, Lim SJ and Kim YW: Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma. Pathology 42: 655-660, 2010.
21. Kim HS, Kim GY, Lim SJ and Kim YW: Raf-1 kinase inhibitory protein expression in thyroid carcinomas. Endocr Pathol 21: 253-257, 2010.
22. Kim HS, Kim GY, Lim SJ, Park YK and Kim YW: Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma. Hum Pathol 41: 1609-1616, 2010.
23. Minoo P, Zlobec I, Baker K, et al: Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 127: 820-827, 2007.
24. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C and Bosserhoff AK: Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 16: 451-456, 2006.
25. Schuierer MM, Bataille F, Hagan S, Kolch W and Bosserhoff AK: Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64: 5186-5192, 2004. (Pubitemid 39006537)
26. Li HZ, Wang Y, Gao Y, et al: Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6: 917-928, 2008.
27. Li HZ, Gao Y, Zhao XL, et al: Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 7: 832-840, 2009.
28. Hu CJ, Zhou L, Zhang J, Huang C and Zhang GM: Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. J Int Med Res 39: 229-237, 2011.
29. Hagan S, Al-Mulla F, Mallon E, et al: Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11: 7392-7397, 2005. (Pubitemid 41507699)
30. Chen Y, Ouyang GL, Yi H, et al: Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J Proteome Res 7: 5254-5262, 2008.
31. Chatterjee D, Sabo E, Tavares R and Resnick MB: Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14: 2994-3001, 2008.
32. Wang J, Yang YH, Wang AQ, et al: Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27: 219-223, 2010.
33. Fu Z, Kitagawa Y, Shen R, et al: Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66: 248-256, 2006. (Pubitemid 43191224)
34. Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L and Lugli A: Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 14: 143-148, 2008. (Pubitemid 351377989)
35. Wanebo HJ, Chu QD, Avradopoulos KA and Vezeridis MP: Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery 119: 361-371, 1996. (Pubitemid 26115827)
36. Adam R, Bismuth H, Castaing D, et al: Repeat hepatectomy for colorectal liver metastases. Ann Surg 225: 51-60, 1997.
37. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M and Rosner MR: Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 278: 13061-13068, 2003. (Pubitemid 36800074)
38. Trakul N, Menard RE, Schade GR, Qian Z and Rosner MR: Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem 280: 24931-24940, 2005. (Pubitemid 40934585)
39. Papin C, Denouel-Galy A, Laugier D, Calothy G and Eychene A: Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J Biol Chem 273: 24939-24947, 1998. (Pubitemid 28455002)
40. Wu X, Noh SJ, Zhou G, Dixon JE and Guan KL: Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated HeLa cells. J Biol Chem 271: 3265-3271, 1996. (Pubitemid 26055630)
41. Gardner AM, Vaillancourt RR, Lange-Carter CA and Johnson GL: MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity. Mol Biol Cell 5: 193-201, 1994. (Pubitemid 24108465)
42. Minoo P, Baker K, Goswami R, et al: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55: 1467-1474, 2006. (Pubitemid 44476793)
43. Martinho O, Gouveia A, Silva P, Pimenta A, Reis RM and Lopes JM: Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch 455: 277-284, 2009.
44. Beach S, Tang H, Park S, et al: Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 27: 2243-2248, 2008. (Pubitemid 351483382)
45. Roy HK, Smyrk TC, Koetsier J, Victor TA and Wali RK: The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig Dis Sci 50: 42-46, 2005. (Pubitemid 40385032)